- Home
- LGVN vs MIRA Comparison
LGVN vs MIRA Comparison
Compare LGVN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- MIRA
- Stock Information
- Founded
- LGVN 2014
- MIRA 2020
- Country
- LGVN United States
- MIRA United States
- Employees
- LGVN N/A
- MIRA N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- MIRA Health Care
- Exchange
- LGVN Nasdaq
- MIRA Nasdaq
- Market Cap
- LGVN 23.4M
- MIRA 19.7M
- IPO Year
- LGVN 2021
- MIRA 2023
- Fundamental
- Price
- LGVN $1.35
- MIRA $1.33
- Analyst Decision
- LGVN Strong Buy
- MIRA Strong Buy
- Analyst Count
- LGVN 3
- MIRA 2
- Target Price
- LGVN $8.67
- MIRA $14.00
- AVG Volume (30 Days)
- LGVN 126.3K
- MIRA 3.4M
- Earning Date
- LGVN 05-08-2025
- MIRA 05-27-2025
- Dividend Yield
- LGVN N/A
- MIRA N/A
- EPS Growth
- LGVN N/A
- MIRA N/A
- EPS
- LGVN N/A
- MIRA N/A
- Revenue
- LGVN $2,225,000.00
- MIRA N/A
- Revenue This Year
- LGVN $1.30
- MIRA N/A
- Revenue Next Year
- LGVN $19.15
- MIRA N/A
- P/E Ratio
- LGVN N/A
- MIRA N/A
- Revenue Growth
- LGVN 127.50
- MIRA N/A
- 52 Week Low
- LGVN $0.77
- MIRA $0.51
- 52 Week High
- LGVN $6.40
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- LGVN 40.87
- MIRA 67.19
- Support Level
- LGVN $1.30
- MIRA $1.03
- Resistance Level
- LGVN $1.52
- MIRA $1.30
- Average True Range (ATR)
- LGVN 0.13
- MIRA 0.11
- MACD
- LGVN -0.02
- MIRA 0.02
- Stochastic Oscillator
- LGVN 9.43
- MIRA 97.44
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.